BUFFALO, NY--(Marketwire - October 24, 2008) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on October 22, 2008, the Company received a letter from The NASDAQ Stock Market notifying the Company that it had ceased to remain in compliance with Marketplace Rule 4450(b)(1) which requires that the Company maintain either (a) a market value of listed securities in excess of $50 million or (b) total assets and total revenues of at least $50 million in the last fiscal year or two of the past three fiscal years. The Company will be provided 30 calendar days to regain compliance, or alternatively may apply for transfer of its listing to The NASDAQ Capital Market.
